Clinical RoundupFree Phase III TOURMALINE-AL1 trial of Ninlaro in patients with amyloidosis didn’t meet one of two primary endpoints December 13, 2019Vol.45 No.46
Clinical RoundupFree Phase III SOPHIA study shows margetuximab didn’t reach significance for OS in HER2+ metastatic breast cancer December 13, 2019Vol.45 No.46
Clinical RoundupFree Keytruda improved OS in frontline metastatic NSCLC regardless of KRAS status December 13, 2019Vol.45 No.46
Clinical RoundupFree Venetoclax in reduced-intensity transplant conditioning regimen in high-risk myeloid cancers shows promise December 13, 2019Vol.45 No.46
FreeTrials & Tribulations Nobel Prize Award: Impact of Clinical Care? December 13, 2019Vol.45 No.46By Ilene Sussman
FreeIn Brief Moderate levels of alcohol consumption linked to higher risk of some cancers, NCI writes in JAMA December 13, 2019Vol.45 No.46
FreeIn Brief MSK to open David H. Koch Center for Cancer Care in January 2020 December 13, 2019Vol.45 No.46
FreeIn Brief Thomas Jefferson University receives $70 million for new biomedical research building December 13, 2019Vol.45 No.46
FreeIn Brief Edmondo Robinson named chief digital innovation officer at Moffitt December 13, 2019Vol.45 No.46
